Ieva Saulīte

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang et al. · OncoImmunology · 2020 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study

Aaron R. Mangold, Agnieszka K. Thompson, Mark D. P. Davis et al. · Journal of the American Academy of Dermatology · 2017 · 48 citations

Medicine, Neurology, Pediatrics +5

Toxic epidermal necrolysis

Wolfram Hoetzenecker, Tarun Mehra, Ieva Saulīte et al. · F1000Research · 2016 · 37 citations · Full text

Medicine, Dermatology, Surgery +15

Proteomic identification of a marker signature for MAPKi resistance in melanoma

Verena Paulitschke, Ossia M. Eichhoff, Christopher Gerner et al. · The EMBO Journal · 2019 · 34 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Expression of CD164 on Malignant T cells in Sézary Syndrome

Emmanuella Guenova, Desislava Ignatova, Yuan Chang et al. · Acta Dermato Venereologica · 2015 · 24 citations · Full text

Medicine, Immunology, Oncology +17